About
APIs
Areas of Focus
Categories
API FocusedChina
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
890
By Phase
PHASE4: 2PHASE2: 2PHASE1/PHASE2: 1
By Status
COMPLETED: 3UNKNOWN: 2
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT05366231Lead Sponsor
Kesuting Syrup in the Treatment of Corona Virus Disease 2019 (COVID-19)
PHASE4Completed
200 participants
Started: May 8, 2022 · Completed: Sep 15, 2022
NCT05007262Lead Sponsor
Tangningtongluo Tablet in the Treatment of Non-proliferative Diabetic Retinopathy
PHASE2Unknown
240 participants
Started: Aug 31, 2021 · Completed: Dec 31, 2023
NCT02484508Lead Sponsor
Multi-center Clinical Study of Guli Capsules in the Treatment of Knee Osteoarthritis
PHASE4Unknown
220 participants
Started: Mar 31, 2015 · Completed: Mar 31, 2016
NCT02161276Lead Sponsor
Clinical Trials for the Optimal Dosage of Tang Ning Tongluo Capsule
PHASE1/PHASE2Completed
110 participants
Started: Apr 30, 2014 · Completed: Sep 30, 2014
NCT02174042Lead Sponsor
The Effect of Tang Ning Tongluo Formula in Type 2 Diabetics Clinical Analysis
PHASE2Completed
120 participants
Started: Mar 31, 2014 · Completed: Sep 30, 2014
Locations (1)
Headquarters
Fuzhou, China
Map
Loading map...